Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Anemia Diagnosed and Monitored Using Advanced Chemiluminescence Technology

By Labmedica staff writers
Posted on 21 Jan 2008
Folate, vitamin B12, and ferritin tests have been developed for an ultra-integrated chemistry analyzer. More...
These tests are used by physicians to diagnose and monitor anemia in patients.

Anemia is characterized by a decreased amount of healthy red blood cells in the circulation or by an abnormally low concentration of hemoglobin, which is needed to carry oxygen throughout the body. Vitamin B12 deficiency anemia, folic acid deficiency anemia, and iron deficiency anemia are among the most commonly diagnosed anemias.

The new tests, which use the luminescence oxygen channeling immunoassay (LOCI) chemiluminescence for testing on the Dimension Vista Intelligent Lab system technology, were added to Siemens' (Deerfield, IL, USA) menu for the detection and differentiation of anemia and iron metabolism. The ultra-integrated chemistry analyzer also provides iron and total iron binding capacity by photometric methodology; and haptoglobin, soluble transferrin receptor, and transferrin testing by nephelometric methodology.

"Anemia is estimated to affect up to 30% of the world's population,” said Jim Reid-Anderson, president, and CEO, Siemens Healthcare Diagnostics. "Early diagnosis and effective treatment of anemia can make a strong contribution to improving patient outcomes and enhancing the quality of life. With the addition of B12, folate, and ferritin to the Dimension Vista Intelligent Lab System test menu, we can further support physicians in advancing the successful treatment of the most common forms of anemia.”

The Dimension Vista Intelligent Lab system menu provides panels for anemia, cardiac disease, thyroid disorders, therapeutic drug monitoring, protein testing, drugs-of-abuse testing, and routine and specialty chemistry testing.


Related Links:
Siemens

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.